IT1259188B - FORMULATIONS TO PROMOTE THE VAGINAL ABSORPTION OF POLYPEPTIDES - Google Patents

FORMULATIONS TO PROMOTE THE VAGINAL ABSORPTION OF POLYPEPTIDES

Info

Publication number
IT1259188B
IT1259188B ITPD920214A ITPD920214A IT1259188B IT 1259188 B IT1259188 B IT 1259188B IT PD920214 A ITPD920214 A IT PD920214A IT PD920214 A ITPD920214 A IT PD920214A IT 1259188 B IT1259188 B IT 1259188B
Authority
IT
Italy
Prior art keywords
formulations
promote
polypeptides
vaginal
polypeptide
Prior art date
Application number
ITPD920214A
Other languages
Italian (it)
Inventor
Luca Benedetti
Lanfranco Callegaro
Original Assignee
Fidia Advanced Biopolymers Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Advanced Biopolymers Srl filed Critical Fidia Advanced Biopolymers Srl
Priority to ITPD920214A priority Critical patent/IT1259188B/en
Publication of ITPD920214A0 publication Critical patent/ITPD920214A0/en
Publication of ITPD920214A1 publication Critical patent/ITPD920214A1/en
Application granted granted Critical
Publication of IT1259188B publication Critical patent/IT1259188B/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invenzione si riferisce a formulazioni farmaceutiche costituite da un polipeptide, ad esempio calcitonina, atte alla somministrazione per via vaginale. Dette formulazioni sono realizzate mediante l'impiego di polimeri semisintetici biocompatibili in forma di microsfere disperse omogeneamente in opportuni eccipienti scelti in modo da garantire la mucoadesivitĂ  delle microsfere all'endotelio della mucosa vaginale e promuovere l'assorbimento transmucosale del polipeptide.The present invention relates to pharmaceutical formulations consisting of a polypeptide, for example calcitonin, suitable for vaginal administration. These formulations are made by using biocompatible semisynthetic polymers in the form of microspheres homogeneously dispersed in suitable excipients chosen so as to guarantee the mucoadhesivity of the microspheres to the endothelium of the vaginal mucosa and promote the transmucosal absorption of the polypeptide.

ITPD920214A 1992-11-25 1992-11-25 FORMULATIONS TO PROMOTE THE VAGINAL ABSORPTION OF POLYPEPTIDES IT1259188B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITPD920214A IT1259188B (en) 1992-11-25 1992-11-25 FORMULATIONS TO PROMOTE THE VAGINAL ABSORPTION OF POLYPEPTIDES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITPD920214A IT1259188B (en) 1992-11-25 1992-11-25 FORMULATIONS TO PROMOTE THE VAGINAL ABSORPTION OF POLYPEPTIDES

Publications (3)

Publication Number Publication Date
ITPD920214A0 ITPD920214A0 (en) 1992-11-25
ITPD920214A1 ITPD920214A1 (en) 1994-05-25
IT1259188B true IT1259188B (en) 1996-03-11

Family

ID=11390105

Family Applications (1)

Application Number Title Priority Date Filing Date
ITPD920214A IT1259188B (en) 1992-11-25 1992-11-25 FORMULATIONS TO PROMOTE THE VAGINAL ABSORPTION OF POLYPEPTIDES

Country Status (1)

Country Link
IT (1) IT1259188B (en)

Also Published As

Publication number Publication date
ITPD920214A1 (en) 1994-05-25
ITPD920214A0 (en) 1992-11-25

Similar Documents

Publication Publication Date Title
AR008378A1 (en) INTERFERON CONJUDATES
IL85523A (en) Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it
KR970706814A (en) Freeze-Dried Ondansetron Compositions
BR9303469A (en) INTERFERON CONJUGATE, COMPOUND, PROCESS OF PREPARATION OF INTERFERON CONJUGATE, USE AND PHARMACEUTICAL COMPOSITES
BR0014652A (en) Manufacture of therapeutic agent-polyglutamate conjugates
MX9702162A (en) Process of making dosage units by wet granulation.
MY129356A (en) Electrospun pharmaceutical compositions
PT828500E (en) UTILIZATION OF FLAVANOLIGNANTS FOR THE PREPARATION OF MEDICINES WITH ANTIPROLIFERATIVE ACTIVITY IN THE OVERSEAS AND MAMA
DK20488A (en) PHARMACEUTICAL PREPARATIONS WITH EXTENDED DELIVERY
IL138665A0 (en) Peptide factor
FI974385A0 (en) Preparation of xylitol For the purpose of pharmaceutical treatment and xylitol preparations For the manufacture of xylitol
DE3875108D1 (en) PHYSIOLOGICALLY ACTIVE POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION.
IT1255723B (en) USE OF PARATORMONE, ITS BIOLOGICALLY ACTIVE FRAGMENTS AND RELATED PEPTIDES, FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION AND THERAPY OF ABORTION AND PRETERMONE BIRTH AND IN GENERAL FOR THE TREATMENT OF GESTATION
EA200400592A1 (en) Conjugates Peptide Thymosin α1 and Polymer
TR199902865T2 (en) Pharmacological compositions of low-resolution peptides in the physiological setting.
IT8920898A0 (en) USE OF WET SUCRALFATE GEL FOR THE TREATMENT OF DERMIC ULCERS AND AS A VEHICLE FOR TOPICAL ACTIVE DRUGS.
IT1259188B (en) FORMULATIONS TO PROMOTE THE VAGINAL ABSORPTION OF POLYPEPTIDES
ATE254851T1 (en) IODINE PRODUCTION COMPOSITION
MXPA02011533A (en) NOVEL FORMULATIONS OF agr; 2, 4 DISULFOPHENYL N TERT BUTYLNITRONE.
IT1204400B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN
TR200401810T4 (en) Use of fsh for infertility treatment
RU2003100517A (en) NEW INTERFERON FOR THE TREATMENT OF MULTIPLE SCLEROSIS
SE8804640L (en) MEDICINAL COMPREHENSIVE CYCLOLINOPEPTIDE A
IT1264546B1 (en) PHARMACEUTICAL COMPOSITION WITH ANTI-ACID ACTIVITY IN THE FORM OF A SUCRALFATE GEL-BASED SUSPENSION
SG48723A1 (en) Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961024